New heart valve device aims to fix leaky valve without open surgery
NCT ID NCT07171060
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This early study tests a new device called the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System in 15 people aged 60-90 with severe tricuspid regurgitation (a leaky heart valve). The goal is to see if the device can be safely implanted and reduce the valve leakage. Participants will be followed to check if the device works well and doesn't cause problems needing further treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunnybrook Research Institute
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.